41 related articles for article (PubMed ID: 38548420)
1. Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice.
Carter TC; Medina-Flores R; Lawler BE
Biomed Res Int; 2018; 2018():6204676. PubMed ID: 30687753
[TBL] [Abstract][Full Text] [Related]
2. Novel Targeting of Transcription and Metabolism in Glioblastoma.
Su YT; Chen R; Wang H; Song H; Zhang Q; Chen LY; Lappin H; Vasconcelos G; Lita A; Maric D; Li A; Celiku O; Zhang W; Meetze K; Estok T; Larion M; Abu-Asab M; Zhuang Z; Yang C; Gilbert MR; Wu J
Clin Cancer Res; 2018 Mar; 24(5):1124-1137. PubMed ID: 29254993
[No Abstract] [Full Text] [Related]
3. Agent-Based Modelling Reveals the Role of the Tumor Microenvironment on the Short-Term Success of Combination Temozolomide/Immune Checkpoint Blockade to Treat Glioblastoma.
Surendran A; Jenner AL; Karimi E; Fiset B; Quail DF; Walsh LA; Craig M
J Pharmacol Exp Ther; 2023 Oct; 387(1):66-77. PubMed ID: 37442619
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma.
Saha D; Rabkin SD; Martuza RL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457126
[TBL] [Abstract][Full Text] [Related]
5. Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model.
Ziani-Zeryouh A; Wouters R; Thirion G; Vandenbrande K; Vankerckhoven A; Berckmans Y; Bevers S; Verbeeck J; De Keersmaecker K; Coosemans A; Riva M
Methods Cell Biol; 2024; 183():381-397. PubMed ID: 38548420
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide for immunomodulation in the treatment of glioblastoma.
Karachi A; Dastmalchi F; Mitchell DA; Rahman M
Neuro Oncol; 2018 Nov; 20(12):1566-1572. PubMed ID: 29733389
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide for high grade glioma.
Hart MG; Garside R; Rogers G; Stein K; Grant R
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.
McBain C; Lawrie TA; Rogozińska E; Kernohan A; Robinson T; Jefferies S
Cochrane Database Syst Rev; 2021 May; 5(1):CD013579. PubMed ID: 34559423
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
[TBL] [Abstract][Full Text] [Related]
10. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma.
Jiapaer S; Furuta T; Tanaka S; Kitabayashi T; Nakada M
Neurol Med Chir (Tokyo); 2018 Oct; 58(10):405-421. PubMed ID: 30249919
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]